Measurement of 111in DTPA clearance during radionuclide cisternography.
A new preparation of 111In DTPA for intrathecal administration has been tested and found to be a safe and highly efficacious cisternographic agent. The rate of removal of 111In DTPA from the C.S.F. and from the whole body has been measured and has been found to be of no diagnostic value in the distinction between patients with cerebral atrophy and those with normotensive hydrocephalus. Long-term retention studies show no evidence of significant long-term retention of indium in the C.S.F. The absorbed radiation dose has been investigated and found to be in good agreement with previous estimates based upon extrapolated data.
D001822:Body Burden; D006801:Humans; D006849:Hydrocephalus / Q000000981:diagnostic imaging*; D007204:Indium; D007278:Injections, Spinal / Q000009:adverse effects; D004369:Pentetic Acid / Q000008:administration & dosage / Q000378:metabolism*; D011011:Pneumoencephalography; D011868:Radioisotopes; D011877:Radionuclide Imaging; D013997:Time Factors
D011868:Radioisotopes; D007204:Indium; D004369:Pentetic Acid